Menu
Nifty
Sensex
:
:
22547.55
74602.12
-5.80 (-0.03%)
147.71 (0.20%)

Pharmaceuticals & Drugs

Rating :
N/A

BSE: 543427 | NSE: MEDPLUS

811.70
06-Feb-2025
  • Open
  • High
  • Low
  • Previous Close
  •  794.60
  •  823.50
  •  779.00
  •  790.40
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  277238
  •  2234.01
  •  875.65
  •  616.00

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 8,607.78
  • 65.02
  • 2
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 8,340.19
  • N/A
  • 5.11

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 40.39%
  • 3.75%
  • 13.21%
  • FII
  • DII
  • Others
  • 15.23%
  • 23.98%
  • 3.44%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • 14.40
  • 14.17

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • 22.67
  • 5.15

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • 105.42
  • -11.92

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • 143.24

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • 5.80

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • 27.18

Earnings Forecasts:

Description
2024
2025
2026
2027
Adj EPS
5.48
11.12
16.36
22.88
P/E Ratio
135.89
66.98
45.52
32.54
Revenue
5625
6366
7421
8631
EBITDA
354
490
607
750
Net Income
65
135
201
281
ROA
2.3
4.3
5.8
7.4
P/Bk Ratio
5.64
5.2
4.68
4.12
ROE
4.27
7.77
10.87
13.52
FCFF
72.88
308.84
262.52
310.04
FCFF Yield
0.74
3.14
2.67
3.15

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Dec 24
Dec 23
Var%
Sep 24
Sep 23
Var%
Jun 24
Jun 23
Var%
Mar 24
Mar 23
Var%
Net Sales
1,561.45
1,441.47
8.32%
1,576.17
1,408.59
11.90%
1,488.83
1,284.30
15.93%
1,490.50
1,252.98
18.96%
Expenses
1,428.92
1,349.69
5.87%
1,451.73
1,323.50
9.69%
1,395.06
1,212.95
15.01%
1,384.63
1,171.35
18.21%
EBITDA
132.52
91.78
44.39%
124.44
85.09
46.25%
93.76
71.34
31.43%
105.87
81.63
29.69%
EBIDTM
8.49%
6.37%
7.89%
6.04%
6.30%
5.56%
7.10%
6.51%
Other Income
12.52
9.79
27.89%
11.60
10.37
11.86%
8.71
9.39
-7.24%
10.46
13.69
-23.59%
Interest
25.97
24.50
6.00%
25.12
23.54
6.71%
24.66
23.27
5.97%
25.13
22.27
12.84%
Depreciation
62.47
57.11
9.39%
63.14
55.47
13.83%
60.03
52.41
14.54%
59.21
55.80
6.11%
PBT
56.60
19.96
183.57%
47.78
16.44
190.63%
17.79
5.05
252.28%
31.99
17.25
85.45%
Tax
10.73
6.26
71.41%
9.08
1.90
377.89%
3.44
1.29
166.67%
-1.58
-9.30
-
PAT
45.87
13.71
234.57%
38.70
14.54
166.16%
14.34
3.76
281.38%
33.56
26.56
26.36%
PATM
2.94%
0.95%
2.46%
1.03%
0.96%
0.29%
2.25%
2.12%
EPS
3.83
1.15
233.04%
3.24
1.22
165.57%
1.20
0.32
275.00%
2.79
2.23
25.11%

Annual Results

Standalone Figures in Rs. Crores /

Consolidated
Description
TTM
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Net Sales
659.72
467.03
213.93
145.71
68.31
61.11
2.55
2.59
3.04
382.11
292.66
Net Sales Growth
62.65%
118.31%
46.82%
113.31%
11.78%
2296.47%
-1.54%
-14.80%
-99.20%
30.56%
 
Cost Of Goods Sold
503.31
351.04
156.87
118.57
50.24
43.53
0.00
0.00
0.00
0.00
0.00
Gross Profit
156.41
116.00
57.05
27.15
18.08
17.59
2.55
2.59
3.04
382.11
292.66
GP Margin
23.71%
24.84%
26.67%
18.63%
26.47%
28.78%
100%
100%
100%
100%
100%
Total Expenditure
592.79
434.71
207.67
142.41
77.11
86.29
4.14
4.25
6.81
383.54
313.26
Power & Fuel Cost
-
4.70
2.57
0.57
0.18
0.06
0.00
0.00
0.00
0.00
0.00
% Of Sales
-
1.01%
1.20%
0.39%
0.26%
0.10%
0%
0%
0%
0%
0%
Employee Cost
-
43.61
28.14
13.73
22.57
6.91
0.00
0.00
0.00
0.00
0.00
% Of Sales
-
9.34%
13.15%
9.42%
33.04%
11.31%
0%
0%
0%
0%
0%
Manufacturing Exp.
-
5.20
1.45
0.51
0.32
1.69
0.00
0.00
0.00
0.00
0.00
% Of Sales
-
1.11%
0.68%
0.35%
0.47%
2.77%
0%
0%
0%
0%
0%
General & Admin Exp.
-
20.34
11.34
4.92
3.48
1.70
4.14
4.25
6.81
383.54
313.26
% Of Sales
-
4.36%
5.30%
3.38%
5.09%
2.78%
162.35%
164.09%
224.01%
100.37%
107.04%
Selling & Distn. Exp.
-
7.83
6.28
3.41
0.07
0.00
0.00
0.00
0.00
0.00
0.00
% Of Sales
-
1.68%
2.94%
2.34%
0.10%
0%
0%
0%
0%
0%
0%
Miscellaneous Exp.
-
2.00
1.00
0.70
0.26
32.41
0.00
0.00
0.00
0.00
0.00
% Of Sales
-
0.43%
0.47%
0.48%
0.38%
53.04%
0%
0%
0%
0%
0%
EBITDA
66.91
32.32
6.26
3.30
-8.80
-25.18
-1.59
-1.66
-3.77
-1.43
-20.60
EBITDA Margin
10.14%
6.92%
2.93%
2.26%
-12.88%
-41.20%
-62.35%
-64.09%
-124.01%
-0.37%
-7.04%
Other Income
8.18
7.29
23.18
9.54
2.11
1.92
0.22
0.47
1.81
2.43
2.89
Interest
8.65
8.40
6.54
2.63
0.56
0.27
1.93
0.51
0.16
0.84
0.00
Depreciation
26.84
24.17
15.31
4.63
1.31
0.84
0.24
0.28
0.33
1.00
1.51
PBT
39.60
7.04
7.59
5.58
-8.57
-24.36
-3.54
-1.99
-2.45
-0.83
-19.22
Tax
3.31
-2.54
2.04
0.00
0.00
0.51
0.00
0.00
0.00
0.00
-0.47
Tax Rate
8.36%
-36.08%
26.88%
0.00%
0.00%
-2.09%
0.00%
0.00%
0.00%
0.00%
2.45%
PAT
36.30
9.58
5.54
5.58
-8.57
-24.87
-7.09
-1.99
-2.45
-8.06
-18.75
PAT before Minority Interest
36.30
9.58
5.54
5.58
-8.57
-24.87
-7.09
-1.99
-2.45
-8.06
-18.75
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PAT Margin
5.50%
2.05%
2.59%
3.83%
-12.55%
-40.70%
-278.04%
-76.83%
-80.59%
-2.11%
-6.41%
PAT Growth
581.05%
72.92%
-0.72%
-
-
-
-
-
-
-
 
EPS
3.04
0.80
0.46
0.47
-0.72
-2.08
-0.59
-0.17
-0.21
-0.67
-1.57

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Shareholder's Funds
1,172.63
1,141.28
1,112.78
517.48
395.61
135.10
142.19
144.18
146.48
93.78
Share Capital
23.91
23.86
23.86
0.45
0.19
0.17
0.17
0.17
0.17
0.15
Total Reserves
1,118.36
1,086.98
1,077.53
468.38
159.28
130.40
137.50
139.49
141.93
88.58
Non-Current Liabilities
82.24
84.69
42.40
7.34
3.45
0.08
0.08
0.07
0.00
15.77
Secured Loans
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
15.77
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Long Term Provisions
3.39
3.88
0.71
0.88
1.10
0.08
0.08
0.07
0.00
0.00
Current Liabilities
55.85
48.01
32.27
23.60
16.17
10.77
9.32
1.15
5.69
29.52
Trade Payables
17.95
12.79
5.53
2.36
1.11
0.73
0.75
1.01
2.74
25.21
Other Current Liabilities
35.98
34.19
26.01
20.58
14.61
0.18
0.37
0.11
2.79
3.92
Short Term Borrowings
0.00
0.00
0.00
0.00
0.00
8.00
8.00
0.00
0.00
0.00
Short Term Provisions
1.92
1.03
0.74
0.66
0.45
1.85
0.20
0.02
0.16
0.39
Total Liabilities
1,310.72
1,273.98
1,187.45
548.42
415.23
145.95
151.59
145.40
152.17
139.07
Net Block
191.68
179.41
85.02
22.68
7.17
1.19
1.57
1.98
2.38
4.86
Gross Block
236.81
201.26
92.46
25.91
9.21
2.18
2.36
2.64
2.72
6.31
Accumulated Depreciation
45.13
21.85
7.45
3.23
2.04
0.99
0.80
0.66
0.34
1.46
Non Current Assets
1,134.79
1,123.40
530.12
441.94
390.32
145.54
147.55
142.72
105.85
6.70
Capital Work in Progress
0.35
17.91
15.52
2.01
0.95
0.00
0.00
0.00
0.00
0.31
Non Current Investment
929.72
917.16
418.45
408.50
381.09
143.63
145.33
139.48
103.48
1.54
Long Term Loans & Adv.
8.04
8.92
11.13
8.75
1.12
0.71
0.65
1.25
0.00
0.00
Other Non Current Assets
5.00
0.00
0.00
0.00
0.00
0.01
0.01
0.01
0.00
0.00
Current Assets
175.93
150.58
657.34
106.48
24.90
0.40
4.04
2.68
46.32
132.37
Current Investments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Inventories
13.96
6.69
3.90
4.79
3.94
0.12
0.12
0.12
0.15
20.50
Sundry Debtors
65.83
37.61
21.29
11.51
8.60
0.14
0.13
0.09
0.15
84.48
Cash & Bank
62.43
90.16
7.44
86.68
10.74
0.03
2.16
2.43
28.62
5.88
Other Current Assets
33.70
1.32
21.57
0.41
1.63
0.11
1.63
0.05
17.40
21.52
Short Term Loans & Adv.
31.48
14.81
603.14
3.10
1.30
0.11
1.62
0.03
16.92
17.91
Net Current Assets
120.08
102.57
625.06
82.88
8.73
-10.36
-5.28
1.53
40.63
102.85
Total Assets
1,310.72
1,273.98
1,187.46
548.42
415.22
145.94
151.59
145.40
152.17
139.07

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Cash From Operating Activity
7.67
11.40
-18.37
-6.24
2.89
-1.80
-0.64
-5.61
-4.05
-6.89
PBT
7.04
7.59
5.58
-8.57
-24.36
-7.09
-1.99
-2.45
-8.06
-19.22
Adjustment
31.11
3.39
0.65
8.22
31.25
0.16
0.03
-0.83
8.71
7.53
Changes in Working Capital
-28.16
2.24
-22.59
-6.17
-4.79
-0.18
0.43
-3.86
-4.71
4.81
Cash after chg. in Working capital
9.99
13.22
-16.36
-6.52
2.10
-7.11
-1.53
-7.13
-4.05
-6.88
Interest Paid
0.00
0.00
0.00
0.00
0.00
1.93
0.51
0.00
0.00
0.00
Tax Paid
-2.32
-1.81
-2.01
0.28
0.79
-0.21
0.29
1.52
0.00
-0.02
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
3.59
0.09
0.00
0.00
0.00
Cash From Investing Activity
-24.43
31.72
-635.99
-14.77
-196.64
1.54
-7.14
-20.40
-11.10
0.71
Net Fixed Assets
-17.99
-111.19
-80.06
-17.76
-7.98
0.18
0.28
0.08
3.90
3.24
Net Investments
-12.56
-498.71
-9.95
-27.41
-237.46
1.70
-5.85
-36.00
-101.94
-1.51
Others
6.12
641.62
-545.98
30.40
48.80
-0.34
-1.57
15.52
86.94
-1.02
Cash from Financing Activity
-5.95
-8.36
568.63
96.94
203.96
-1.87
7.51
-0.16
43.39
6.25
Net Cash Inflow / Outflow
-22.70
34.77
-85.74
75.94
10.21
-2.13
-0.27
-26.18
28.24
0.07
Opening Cash & Equivalents
35.70
0.94
86.68
10.74
0.53
2.16
2.43
28.61
0.37
0.31
Closing Cash & Equivalent
13.00
35.70
0.94
86.68
10.74
0.03
2.16
2.43
28.61
0.37

Financial Ratios

Standalone /

Consolidated
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Book Value (Rs.)
95.56
93.11
92.32
2092.97
8220.31
7761.29
8182.90
8301.20
8446.76
5835.11
ROA
0.74%
0.45%
0.64%
-1.78%
-8.20%
-4.77%
-1.34%
-1.65%
-5.53%
-13.59%
ROE
0.85%
0.50%
0.71%
-2.73%
-14.80%
-5.29%
-1.44%
-1.74%
-6.98%
-19.11%
ROCE
1.33%
1.25%
1.01%
-1.75%
-8.30%
-3.52%
-1.00%
-1.57%
-5.64%
-17.04%
Fixed Asset Turnover
2.31
1.57
2.63
3.98
11.59
1.12
1.03
1.13
84.62
37.78
Receivable days
37.37
46.56
38.38
52.46
31.88
19.40
15.57
14.06
40.42
104.89
Inventory Days
7.46
8.37
10.16
22.76
12.43
17.35
16.63
16.21
9.87
23.98
Payable days
15.98
21.31
12.15
12.61
22.26
1130.61
1132.69
2107.52
5120.81
4171.22
Cash Conversion Cycle
28.85
33.62
36.39
62.61
22.06
-1093.85
-1100.48
-2077.26
-5070.53
-4042.34
Total Debt/Equity
0.00
0.00
0.00
0.00
0.00
0.06
0.06
0.00
0.00
0.18
Interest Cover
1.84
2.16
3.12
-14.16
-89.56
-2.67
-2.89
-14.12
-8.62
0.00

News Update:


  • Medplus Health Servi - Quarterly Results
    31st Jan 2025, 17:14 PM

    Read More
  • Premji Invest, SBI Mutual Fund divest 6.6% stake in MedPlus Health Services
    19th Nov 2024, 11:30 AM

    The shares were sold at an average price of Rs 700 apiece, taking the transaction value to Rs 552.55 crore

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.